Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 1997-06-01 (28 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ORVAULT (44700), Loire-Atlantique
PHARMACIE DE LA CHOLIERE : revenue, balance sheet and financial ratios
PHARMACIE DE LA CHOLIERE is a French company
founded 28 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ORVAULT (44700),
this company of category PME
shows in 2023 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA CHOLIERE (SIREN 412186173)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
2 238 057 €
2 375 184 €
1 849 568 €
1 756 446 €
N/C
N/C
N/C
Net income
97 368 €
131 077 €
266 738 €
158 995 €
124 044 €
146 378 €
141 675 €
138 001 €
EBITDA
N/C
156 864 €
344 730 €
209 458 €
164 714 €
N/C
N/C
N/C
Net margin
N/C
5.9%
11.2%
8.6%
7.1%
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LA CHOLIERE generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 138 k€ -> 97 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
97 368 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 82%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.783%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.807%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA CHOLIERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
4.651
4.117
3.703
1.548
4.008
1.062
0.736
0.783
Financial autonomy
79.906
82.79
81.78
84.13
82.133
79.934
85.354
81.807
Repayment capacity
None
None
None
0.158
0.342
0.052
0.073
None
Cash flow / Revenue
None%
None%
None%
6.964%
8.328%
10.702%
6.166%
None%
Sector positioning
Debt ratio
0.782024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE DE LA CHOLIERE (0.78) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.81%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA CHOLIERE (81.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.07 years2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DE LA CHOLIERE (0.07) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 175.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
175.655
Liquidity indicators evolution PHARMACIE DE LA CHOLIERE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
196.99
214.068
243.034
252.474
286.275
212.798
296.327
175.655
Interest coverage
None
None
None
0.0
0.0
0.0
0.683
None
Sector positioning
Liquidity ratio
175.662024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-8 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA CHOLIERE (175.66) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
0.68x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DE LA CHOLIERE (0.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA CHOLIERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
321 693 €
325 746 €
223 196 €
450 252 €
0 €
Inventory turnover (days)
0
0
0
34
34
27
28
0
Customer payment term (days)
77
119
78
5
6
4
4
0
Supplier payment term (days)
1113
775
974
47
52
52
38
0
Positioning of PHARMACIE DE LA CHOLIERE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA CHOLIERE is estimated at
1 359 329 €
(range 946 615€ - 2 033 634€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
946k€1359k€2033k€
1 359 329 €Range: 946 615€ - 2 033 634€
NAF 5 année 2024
Valuation method used
Net Income Multiple
97 368 €
×
14.0x
=1 359 329 €
Range: 946 615€ - 2 033 634€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA CHOLIERE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA CHOLIERE
What is the revenue of PHARMACIE DE LA CHOLIERE ?
The revenue of PHARMACIE DE LA CHOLIERE in 2023 is 2.2 M€.
Is PHARMACIE DE LA CHOLIERE profitable?
Yes, PHARMACIE DE LA CHOLIERE generated a net profit of 97 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA CHOLIERE ?
The headquarters of PHARMACIE DE LA CHOLIERE is located in ORVAULT (44700), in the department Loire-Atlantique.
Where to find the tax return of PHARMACIE DE LA CHOLIERE ?
The tax return of PHARMACIE DE LA CHOLIERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA CHOLIERE operate?
PHARMACIE DE LA CHOLIERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart